{"id":"NCT03277105","sponsor":"Janssen Research & Development, LLC","briefTitle":"A Study of Subcutaneous Versus (vs.) Intravenous Administration of Daratumumab in Participants With Relapsed or Refractory Multiple Myeloma","officialTitle":"A Phase 3 Randomized, Multicenter Study of Subcutaneous vs. Intravenous Administration of Daratumumab in Subjects With Relapsed or Refractory Multiple Myeloma","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-10-27","primaryCompletion":"2019-06-27","completion":"2024-01-12","firstPosted":"2017-09-08","resultsPosted":"2020-07-27","lastUpdate":"2025-04-29"},"enrollment":522,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Multiple Myeloma"],"interventions":[{"type":"DRUG","name":"Dara SC","otherNames":[]},{"type":"DRUG","name":"Dara IV","otherNames":["JNJ-54767414"]}],"arms":[{"label":"Dara SC","type":"EXPERIMENTAL"},{"label":"Dara IV","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to show that subcutaneous (SC) administration of daratumumab co-formulated with recombinant human hyaluronidase PH20 (Dara SC) is non-inferior to intravenous (IV) administration of daratumumab (Dara IV) in terms of the overall response rate (ORR) and maximum trough concentration (Ctrough).","primaryOutcome":{"measure":"Overall Response Rate (ORR)","timeFrame":"Up to 1 year 8 months","effectByArm":[{"arm":"Daratumumab IV","deltaMin":39.4,"sd":null},{"arm":"Daratumumab SC","deltaMin":43.3,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":5},"locations":{"siteCount":146,"countries":["United States","Australia","Brazil","Canada","Czechia","France","Greece","Israel","Italy","Japan","Poland","Russia","South Korea","Spain","Sweden","Taiwan","Ukraine","United Kingdom"]},"refs":{"pmids":["39971605","37022569","35354247","33599794","32852632","32213342"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":89,"n":258},"commonTop":["Anaemia","Thrombocytopenia","Neutropenia","Upper Respiratory Tract Infection","Diarrhoea"]}}